Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Tangerina Mix

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Tina Gel Sweet Flower.

Inclusion Criteria:

• Integral skin test in the region;

Exclusion Criteria:

• Lactation or gestational risk or gestation;
• Use of Anti-inflammatory or immunosuppression drugs 1 month before the study;
• Topical medication use at the region to be treated;
• Cutaneous disease or active gynecological disease which may interfere in study results;
• Personal history of allergic disease at the area to be treated;
• Allergic or atopic history;

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.